Skip to main content

3 Result(s)

within S Samiee Remove this filter Public Health Remove this filter

and

  1. No Access

    Article

    Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients

    Busulfan and cyclophosphamide (BuCy) are currently the most widely used myeloablative regimen to treat malignancies with allogeneic stem cell transplantation. Fludarabine has considerable efficacy in both immu...

    M Iravani, M R Evazi, S A Mousavi, A R Shamshiri, M Tavakoli… in Bone Marrow Transplantation (2007)

  2. No Access

    Article

    Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation

    Genetic aberrations have emerged as major prognostic factors for patients with multiple myeloma (MM). We evaluated 126 MM patients for t(4;14) or t(11;14), 13q or p53 deletions and correlated the number of gen...

    H Chang, X Y Qi, S Samiee, Q-L Yi, C Chen, S Trudel… in Bone Marrow Transplantation (2005)

  3. No Access

    Article

    Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation

    We compared the effects of cyclosporin A (CsA) alone as graft-versus-host disease (GVHD) prophylaxis vs cyclosporine with short-course methotrexate (MTX) in patients with thalassemia. In all, 140 patients were en...

    M Iravani, A Mousavi, S Gholibeikian, B Bahar, S Samiee… in Bone Marrow Transplantation (2005)